Open Access Paper
13 May 2011 Cancer nanotechnology: a new commercialization pipeline for diagnostics, imaging agents, and therapies
Krzysztof Ptak, Dorothy Farrell, George Hinkal, Nicholas J. Panaro, Sara Hook, Piotr Grodzinski
Author Affiliations +
Abstract
Nanotechnology - the science and engineering of manipulating matter at the molecular scale to create devices with novel chemical, physical and biological properties - has the potential to radically change oncology. Research sponsored by the NCI Alliance for Nanotechnology in Cancer has led to the development of nanomaterials as platforms of increasing complexity and devices of superior sensitivity, speed and multiplexing capability. Input from clinicians has guided researchers in the design of technologies to address specific needs in the areas of cancer therapy and therapeutic monitoring, in vivo imaging, and in vitro diagnostics. The promising output from the Alliance has led to many new companies being founded to commercialize their nanomedical product line. Furthermore, several of these technologies, which are discussed in this paper, have advanced to clinically testing.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Krzysztof Ptak, Dorothy Farrell, George Hinkal, Nicholas J. Panaro, Sara Hook, and Piotr Grodzinski "Cancer nanotechnology: a new commercialization pipeline for diagnostics, imaging agents, and therapies", Proc. SPIE 8031, Micro- and Nanotechnology Sensors, Systems, and Applications III, 80311S (13 May 2011); https://doi.org/10.1117/12.884607
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Nanotechnology

Nanoparticles

Proteins

Therapeutics

Diagnostics

Raman spectroscopy

Back to Top